561 related articles for article (PubMed ID: 28114348)
1. Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.
Rodrigues ME; Lopes SP; Pereira CR; Azevedo NF; Lourenço A; Henriques M; Pereira MO
PLoS One; 2017; 12(1):e0170433. PubMed ID: 28114348
[TBL] [Abstract][Full Text] [Related]
2. In vitro interactions between fluconazole and minocycline against mixed cultures of Candida albicans and Staphylococcus aureus.
Li H; Zhang C; Liu P; Liu W; Gao Y; Sun S
J Microbiol Immunol Infect; 2015 Dec; 48(6):655-61. PubMed ID: 24856422
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa increases the susceptibility of Candida albicans to amphotericin B in dual-species biofilms.
Alam F; Blackburn SA; Davis J; Massar K; Correia J; Tsai HJ; Blair JMA; Hall RA
J Antimicrob Chemother; 2023 Sep; 78(9):2228-2241. PubMed ID: 37522316
[TBL] [Abstract][Full Text] [Related]
4. Phage-antibiotic combinations to control Pseudomonas aeruginosa-Candida two-species biofilms.
Manohar P; Loh B; Nachimuthu R; Leptihn S
Sci Rep; 2024 Apr; 14(1):9354. PubMed ID: 38653744
[TBL] [Abstract][Full Text] [Related]
5. Searching for new strategies against polymicrobial biofilm infections: guanylated polymethacrylates kill mixed fungal/bacterial biofilms.
Qu Y; Locock K; Verma-Gaur J; Hay ID; Meagher L; Traven A
J Antimicrob Chemother; 2016 Feb; 71(2):413-21. PubMed ID: 26490013
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
7. Targeting Candida albicans in dual-species biofilms with antifungal treatment reduces Staphylococcus aureus and MRSA in vitro.
Luo Y; McAuley DF; Fulton CR; Sá Pessoa J; McMullan R; Lundy FT
PLoS One; 2021; 16(4):e0249547. PubMed ID: 33831044
[TBL] [Abstract][Full Text] [Related]
8. Prolonged inhibitory effects against planktonic growth, adherence, and biofilm formation of pathogens causing ventilator-associated pneumonia using a novel polyamide/silver nanoparticle composite-coated endotracheal tube.
Lethongkam S; Daengngam C; Tansakul C; Siri R; Chumpraman A; Phengmak M; Voravuthikunchai SP
Biofouling; 2020 Mar; 36(3):292-307. PubMed ID: 32367731
[TBL] [Abstract][Full Text] [Related]
9. Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.
Manavathu EK; Vager DL; Vazquez JA
BMC Microbiol; 2014 Mar; 14():53. PubMed ID: 24588809
[TBL] [Abstract][Full Text] [Related]
10. Cutibacterium acnes protects Candida albicans from the effect of micafungin in biofilms.
Bernard C; Renaudeau N; Mollichella ML; Quellard N; Girardot M; Imbert C
Int J Antimicrob Agents; 2018 Dec; 52(6):942-946. PubMed ID: 30144502
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
12. The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents.
Al-Bakri AG; Othman G; Bustanji Y
J Appl Microbiol; 2009 Jul; 107(1):280-6. PubMed ID: 19302313
[TBL] [Abstract][Full Text] [Related]
13. [Anti-candidal activity of clinical Pseudomonas aeruginosa strains and in vitro inhibition of Candida biofilm formation].
Keçeli Özcan S; Dündar D; Sönmez Tamer G
Mikrobiyol Bul; 2012 Jan; 46(1):39-46. PubMed ID: 22399170
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
15. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.
Maurice NM; Bedi B; Sadikot RT
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):428-439. PubMed ID: 29372812
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures.
Hendry ER; Worthington T; Conway BR; Lambert PA
J Antimicrob Chemother; 2009 Dec; 64(6):1219-25. PubMed ID: 19837714
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin and Polymyxin B Reduce the Cell Viability and Total Biomass of Mixed Biofilms of Carbapenem-Resistant
Fernandes L; Fortes BN; Lincopan N; Ishida K
Front Microbiol; 2020; 11():573263. PubMed ID: 33391197
[No Abstract] [Full Text] [Related]
19. Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study.
Nseir S; Jozefowicz E; Cavestri B; Sendid B; Di Pompeo C; Dewavrin F; Favory R; Roussel-Delvallez M; Durocher A
Intensive Care Med; 2007 Jan; 33(1):137-42. PubMed ID: 17115135
[TBL] [Abstract][Full Text] [Related]
20. Prevention of polymicrobial biofilms composed of Pseudomonas aeruginosa and pathogenic fungi by essential oils from selected Citrus species.
Pekmezovic M; Aleksic I; Barac A; Arsic-Arsenijevic V; Vasiljevic B; Nikodinovic-Runic J; Senerovic L
Pathog Dis; 2016 Nov; 74(8):. PubMed ID: 27702795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
